DOCSLIB.ORG

Alcohol Dehydrogenase

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Alcohol Dehydrogenase Catalog Number: 100161, 151430, 159858 Alcohol Dehydrogenase Molecular Weight: 141,000 comprised of four subunits of 35,000 each.8 CAS # : 9031-72-5 Synonyms: ADH; Alcohol : NAD+ oxidoreductase Source: Yeast E.C. 1.1.1.1 Description: Alcohol dehydrogenase catalyzes the reaction: The common reaction in yeast cells is reduction of acetaldehyde to ethanol. In vitro the enzyme is generally assayed and used in a more alkaline pH region, a condition which favors a shift of equilibrium towards the oxidation of ethanol. Composition: A metalloenzyme containing four tightly bound zinc atoms per molecule.18,19 Per subunit, there are two distinct active site sulfhydryl groups which can be distinguished on the basis of differential reactivity with iodoacetate and butyl isocyanate.17 A histidine residue is considered to have an essential role.9 Optimum pH: For the oxidation of ethanol, pH 8.6-9.0 (the enzyme becomes increasingly unstable at higher pH). For the reduction of acetaldehyde a pH nearer to 7.0 is considered optimum. This reaction is kinetically complex with pH being only one factor determining optimum conditions. 1% Extinction coefficient: E 260= 12.6. Isoelectric point: 5.4.16 Solubility: Dissolves readily at 5 mg/ml in 0.01 M sodium phosphate pH 7.5 to give a clear colorless solution. Activators: Sulfyhydryl activating reagents, mercaptoethanol, dithiothreitol, cysteine, etc., and heavy metal chelating reagents. Specificity: Yeast ADH which has a more narrow specificity than that of liver enzyme, accepts ethanol, is somewhat active on the straight chain primary alcohols, and acts to a very limited extent on certain secondary and branched chain alcohols.10 NADP does not serve as coenzyme. Inhibitors: Heavy metals and -SH reagents. See Sund and Theorell16 for a more comprehensive list; also Anderson and Reynolds2, Anderson et al.3, Atkinson et al.5, Fiddick and Heath11, Rashed and Rabin15. Stabilizers: Dilute solution of the enzyme may be stabilized by serum albumin, gelatin, and/or glutathione or cysteine. At pH values below 6.0 and above 8.5 the enzyme is increasingly unstable. More concentrated solutions of the enzyme in high purity water, near neutrality, are stable several days at 5oC. Assay Method: The reaction velocity is determined by the method of Vallee and Hoch18,19 in which the rate of absorbance at 340 nm resulting from reduction of NAD is measured. One unit reduces one micromole of NAD per minute at 25oC under the specified conditions. Reagents 0.1 M Sodium pyrophosphate buffer, pH 9.2 2 M Ethanol. Dilute 12.12 ml of 95% ethanol to 100 ml with reagent grade water. 0.025 M NAD. Note: NAD may vary in salt form and degree of hydration. Care should be exercised to use an analytical grade and the correct molecular weight. 0.1 M Phosphate buffer, pH 7.5 0.1% Albumin (BSA) in 0.01 M phosphate buffer, pH 7.5 Enzyme Dissolve lyophilized enzyme at one mg/ml in 0.1 M phosphate buffer, pH 7.5. Immediately prior to use, dilute all enzymes to a concentration of 0.05-0.25 units/ml in 0.1% albumin. For yeast enzyme: mg/ml = A260 x 0.796 For protein determinations, dissolve enzyme in 0.1 M phosphate buffer, pH 7.5. Procedure Set spectrophotometer to 340 nm and 25oC. Pipette into each cuvette: 0.1 M Pyrophosphate buffer 1.5 ml 2.0 M Ethanol 0.5 ml 0.025 M NAD 1.0 ml Incubate in spectrophotometer for 3-4 minutes at 25oC to achieve temperature equilibrium and establish blank rate, if any. At zero time, add 0.1 ml of appropriately diluted enzyme to the cuvette and record the A340 for 3-4 minutes. Calculate the A340/minute from the initial linear portion of the curve. Calculation Units/mg protein = (DA340/min) / (6.22 x mg protein/ml reaction mixture) Availability: Catalog Number Description Size 100161 Alcohol Dehydrogenase, 2X crystallized, 7.5 KU lyophilized. Activity: approximately 300 15 KU units/mg 30 KU 75 KU 150 KU 500 KU 151430 Alcohol Dehydrogenase, lyophilized 25 mg powder. Activity: not less than 300 units/mg 250 mg protein 500 mg 159858 Alcohol Dehydrogenase, 2X crystallized, 100 mg suspension in 2.4 M ammonium sulfate 500 mg containing 3% pyrophosphate and 1% glycine References: 1. Ainslie, G., and Cleland, W., "Isotope Exchange Studies on Liver Alcohol Dehydrogenase with Cyclohexamol and Cyclohexanone as Reductants," J. Biol. Chem., v. 247, 946 (1972). 2. Anderson, B., and Reynolds, M., "Multiple Inhibition of Yeast Alcohol Dehydrogenase by Heterocyclic Nitrogen Bases," Arch. Biochem. Biophys., v. 114, 299 (1966). 3. Anderson, B., Reynolds, M., and Anderson, C., "Nitrogen Base Inhibition of Yeast Alcohol Dehydrogenase," Biochim. Biophys. Acta, v. 113, 235 (1966). 4. Andersson, P., Kvassman, J., Oldén, B., and Pettersson, G., "Electrostatic Field Effects of Coenzymes on Ligand Binding to Catalytic Zinc in Liver Alcohol Dehydrogenase," Eur. J. Biochem., v. 138, 603 (1984). 5. Atkinson, M., Eckermann, G., and Lilley, R., "Inhibition of Alcohol Dehydrogenase from Yeast by Pyridine," Biochem. J., v. 104, 872 (1967). 6. Baillie, A., Calman, K., and Hart, D., "Histochemical Distribution of Alcohol Dehydrogenases in Endocrine Tissue," Nature, v. 210, 1277 (1966). 7. Brändén, C., Jörnvall, H., Eklund, H., and Furugren, B., "Alcohol Dehydrogenases" in The Enzymes, XI, 3rd ed., Part A, (Boyer, P., ed.), Academic Press, NY, 103 (1975). 8. Büchner, M., and Sund, H., "Yeast Alcohol Dehydrogenase: -SH Groups, Di-sulfide Groups, Quaternary Structure, and Reactivation by Reductive Cleavage of Disulfide Groups," Eur. J. Biochem., v. 11, 73 (1969). 9. Dickenson, C., and Dickinson, F., "The Role of an Essential Histidine Residue of Yeast Alcohol Dehydrogenase," Eur. J. Biochem., v. 52, 595 (1975). 10. Dickinson, F., and Dalziel, K., "Substrate Specificity and Stereospecificity of Alcohol Dehydrogenases," Nature, v. 214, 31 (1967). 11. Fiddick, R., and Heath, H., "Inhibition of Alcohol Dehydrogenase by Chloroquine," Nature, v. 213, 628 (1967). 12. Jörnvall, H., "Partial Similarities Between Yeast and Liver Alcohol Dehydrogenases," Proc. Natl. Acad. Sci. USA, v. 70, 2295 (1973). 13. Myers, J., and Jakoby, B., "Glycerol as an Agent Eliciting Small Conformational Changes in Alcohol Dehydrogenase," J. Biol. Chem., v. 250, 3785 (1975). 14. Pereira, E., Aracava, Y., Aronstam, R., Barreiro, E., and Albuquerque, E., "Pyrazole, an Alcohol Dehydrogenase Inhibitor, Has Dual Effects on Normal-Methyl-D-Aspartate Receptors of Hippocampal Pyramidal Cells - Agonist and Noncompetitive Antagonist," J. Pharm. Exp. Ther., v. 261, 331 (1992). 15. Rashed, N., and Rabin, B., "Inhibition of Yeast Alcohol Dehydrogenase by Alkylating Agents," Eur. J. Biochem., v. 5, 147 (1968). 16. Sund, H., and Theorell, H., "Alcohol Dehydrogenases" in The Enzymes, VII, 2nd ed., (Boyer, P., Lardy, H., and Myrback, K., eds.), Academic Press, NY, p. 25 (1963). 17. Twu, J., Chin, C., and Wold, F., "Studies on the Active-Site Sulfhydryl Groups of Yeast Alcohol Dehydrogenase," Biochem., v. 12, 2856 (1973). 18. Vallee, B., and Hoch, F., J.A.C.S., v. 77, 821 (1955). 19. Vallee, B., and Hoch, F., "Zinc: A Component of Yeast Alcohol Dehydrogenase," Proc. Natl. Acad. Sci. USA, v. 41, 327 (1955)..
Load more

Recommended publications
  • Dehydrogenase Gene of Entamoeba Histolytica
    Proc. Nad. Acad. Sci. USA Vol. 89, pp. 10188-10192, November 1992 Medical Sciences Cloning and expression of an NADP+-dependent alcohol dehydrogenase gene of Entamoeba histolytica (amebiasis/protozoan parasite/fermentation/inhibitors) AJIT KUMAR*, PEI-SHEN SHENtt, STEVEN DESCOTEAUX*, JAN POHL§, GORDON BAILEYt, AND JOHN SAMUELSON*1II *Department of Tropical Public Health, Harvard School of Public Health, Boston, MA 02115; tDepartment of Biochemistry, Morehouse School of Medicine, Atlanta, GA 30310; §Microchemical Facility, Emory University, Atlanta, GA 30322; and 'Department of Pathology, New England Deaconess Hospital, Boston, MA 02215 Communicated by Elkan Blout, June 29, 1992 (receivedfor review May 1, 1992) ABSTRACT Ethanol is the major metabolic product of NAD(P)+ so that the reducing equivalents are regenerated glucose fermentation by the protozoan parasite Entmoeba (4-7). Both NADP+-dependent and NAD+-dependent alco- histolytica under the anaerobic conditions found in the lumen hol dehydrogenase (ADH) activities have been identified in of the colon. Here an internal peptide sequence determined E. histolytica trophozoites (4-7). The NADP+-dependent from a major 39-kDa amoeba protein isolated by isoeLtric ADH (EhADHi; EC 1.1.1.2) was found to be composed of focusing followed by SDS/PAGE was used to clone the gene for four -30-kDa subunits, prefer secondary alcohols to primary the E. histolytica NADP+-dependent alcohol dehydrogenase alcohols, and be inhibited by the substrate analogue pyrazole (EhADH1; EC 1.1.1.2). The EhADHi clone had an open (7). The amoeba NAD+-dependent ADH (EC 1.1.1.1) is not reading frame that was 360 amino acids long and encoded a well-characterized (4).
    [Show full text]
  • Is There a Role for Ethanol Assay Using Alcohol Dehydrogenase in a Basic Drugs and Alcohol Screen of Blood Following Routine Autopsies?
    Journal of Clinical Pathology and Forensic Medicine Vol. 3(2), pp. 17-19, December 2012 Available online at http://www.academicjournals.org/JCPFM DOI: 10.5897/JCPFM12.003 ISSN 2I41-2405 ©2012 Academic Journals Short Communication Is there a role for ethanol assay using alcohol dehydrogenase in a basic drugs and alcohol screen of blood following routine autopsies? William Tormey 1,2 and Tara Moore 3 1Biomedical Sciences, University of Ulster Cromore Road, Coleraine, BT52 1SA, Northern Ireland. 2Department of Chemical Pathology, Beaumont Hospital, Dublin 9, Ireland. 3Biomedical Sciences, University of Ulster, Cromore Road, Coleraine, BT52 1SA, Northern Ireland. Accepted 22 March, 2012 The external examination system of determining the cause of death as operated in Dundee, Scotland is controversial. The addition of a blood or urine specimen for drugs and alcohol processed by hospital autoanalysers will reduce error in death certification. This is even more convenient to organise with a shorter turn-around time than imaging by computed tomography (CT) or magnetic resonance imaging (MRI). These measures may reduce the autopsy rate and ameliorate the distress of families of the deceased. Key words: Autopsy, alcohol, death. INTRODUCTION For over a decade, there has been controversy over the dehydrogenase and the back reaction nicotinamide appropriateness of the high rate of coroner’s autopsies adenine dinucleotide (NAD) to NADH measured (Pounder, 2000; Rutty et al., 2001). Advocacy of the spectrophotometrically at 340 nm on the Olympus 5400 “view and grant” system of issuing the cause of death as autoanalyser for the analysis of alcohol. The data sheet operated in Dundee, Scotland has been challenged and claims that the assay can accurately quantitate alcohol imaging is suggested as a partial answer to lessen the concentrations within the range of 10 to 600 mg/dl.
    [Show full text]
  • How Is Alcohol Metabolized by the Body?
    Overview: How Is Alcohol Metabolized by the Body? Samir Zakhari, Ph.D. Alcohol is eliminated from the body by various metabolic mechanisms. The primary enzymes involved are aldehyde dehydrogenase (ALDH), alcohol dehydrogenase (ADH), cytochrome P450 (CYP2E1), and catalase. Variations in the genes for these enzymes have been found to influence alcohol consumption, alcohol-related tissue damage, and alcohol dependence. The consequences of alcohol metabolism include oxygen deficits (i.e., hypoxia) in the liver; interaction between alcohol metabolism byproducts and other cell components, resulting in the formation of harmful compounds (i.e., adducts); formation of highly reactive oxygen-containing molecules (i.e., reactive oxygen species [ROS]) that can damage other cell components; changes in the ratio of NADH to NAD+ (i.e., the cell’s redox state); tissue damage; fetal damage; impairment of other metabolic processes; cancer; and medication interactions. Several issues related to alcohol metabolism require further research. KEY WORDS: Ethanol-to­ acetaldehyde metabolism; alcohol dehydrogenase (ADH); aldehyde dehydrogenase (ALDH); acetaldehyde; acetate; cytochrome P450 2E1 (CYP2E1); catalase; reactive oxygen species (ROS); blood alcohol concentration (BAC); liver; stomach; brain; fetal alcohol effects; genetics and heredity; ethnic group; hypoxia The alcohol elimination rate varies state of liver cells. Chronic alcohol con- he effects of alcohol (i.e., ethanol) widely (i.e., three-fold) among individ- sumption and alcohol metabolism are on various tissues depend on its uals and is influenced by factors such as strongly linked to several pathological concentration in the blood T chronic alcohol consumption, diet, age, consequences and tissue damage. (blood alcohol concentration [BAC]) smoking, and time of day (Bennion and Understanding the balance of alcohol’s over time.
    [Show full text]
  • 1 Here Are the Quiz 4 Questions You Will Answer Online Using the Quiz
    Chemistry 6720, quiz 4 handout Here are the quiz 4 questions you will answer online using the quiz tool in canvas instructure. Some of the questions deal with citric acid cycle enzymes that use mechanistic strategies covered in the lectures. Since we did not cover all of those specific enzymes in lecture, be sure to review the citric acid cycle ahead of taking the quiz online so you can answer the appropriate questions regarding mechanistic strategies/themes for the enzymes. In doing so, practice drawing mechanisms for each enzyme of the citric acid cycle. You will probably need to look up the mechanisms for isocitrate dehydrogenase, aconitase, succinate dehydrogenase, and succinyl-CoA synthetase in a general biochemistry text. I will not be asking specific details of the mechanisms for those 4 enzymes, but you will still need to be generally familiar with how they operate to answer a few of the questions below. You do not need to know the chemistry of FAD reduction for the quiz. Be sure to note the quiz deadline in canvas to be sure you get your answers submitted by the deadline. 1. Shown at the right is a Fischer projection for D-glucose. Use the strategy described in the lecture to assign the configurations (R or S) of the chiral centers at C2, C3, C4, and C5. 2. Using the structures shown to the right, assign the methyl groups of isopropanol, and the hydrogens at C2 and C3 of succinate, as either ProR or ProS. Use the strategy covered in lecture to guide you in making the assignments.
    [Show full text]
  • Original Article Compensatory Upregulation of Aldo-Keto Reductase 1B10 to Protect Hepatocytes Against Oxidative Stress During Hepatocarcinogenesis
    Am J Cancer Res 2019;9(12):2730-2748 www.ajcr.us /ISSN:2156-6976/ajcr0097527 Original Article Compensatory upregulation of aldo-keto reductase 1B10 to protect hepatocytes against oxidative stress during hepatocarcinogenesis Yongzhen Liu1, Jing Zhang1, Hui Liu1, Guiwen Guan1, Ting Zhang1, Leijie Wang1, Xuewei Qi1, Huiling Zheng1, Chia-Chen Chen1, Jia Liu1, Deliang Cao2, Fengmin Lu3, Xiangmei Chen1 1State Key Laboratory of Natural and Biomimetic Drugs, Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, P. R. China; 2Department of Medical Microbiology, Immunology and Cell Biology, Simmons Cancer Institute at Southern Illinois University School of Medicine, 913 N, Rutledge Street, Springfield, IL 62794, USA; 3Peking University People’s Hospital, Peking University Hepatology Institute, Beijing 100044, P. R. China Received May 26, 2019; Accepted November 15, 2019; Epub December 1, 2019; Published December 15, 2019 Abstract: Aldo-keto reductase 1B10 (AKR1B10), a member of aldo-keto reductase superfamily, contributes to detox- ification of xenobiotics and metabolization of physiological substrates. Although increased expression of AKR1B10 was found in hepatocellular carcinoma (HCC), the role of AKR1B10 in the development of HCC remains unclear. This study aims to illustrate the role of AKR1B10 in hepatocarcinogenesis based on its intrinsic oxidoreduction abilities. HCC cell lines with AKR1B10 overexpression or knockdown were treated with doxorubicin or hydrogen peroxide to determinate the influence of aberrant AKR1B10 expression on cells’ response to oxidative stress. Using Akr1b8 (the ortholog of human AKR1B10) knockout mice, diethylnitrosamine (DEN) induced liver injury, chronic inflammation and hepatocarcinogenesis were explored. Clinically, the pattern of serum AKR1B10 relevant to disease progres- sion was investigated in a patient cohort with chronic hepatitis B (n=30), liver cirrhosis (n=30) and HCC (n=40).
    [Show full text]
  • Alcohol Dehydrogenase Activity in Lactococcus Chungangensis: Application in Cream Cheese to Moderate Alcohol Uptake
    J. Dairy Sci. 98:5974–5982 http://dx.doi.org/10.3168/jds.2015-9697 © American Dairy Science Association®, 2015. Alcohol dehydrogenase activity in Lactococcus chungangensis: Application in cream cheese to moderate alcohol uptake Maytiya Konkit, Woo Jin Choi, and Wonyong Kim1 Department of Microbiology, Chung-Ang University College of Medicine, Seoul 156-756, Republic of Korea ABSTRACT teroides (Molimard and Spinnler, 1996; Bockelmann et al., 1997; Beresford et al., 2001; Bockelmann and Many human gastrointestinal facultative anaerobic Hoppe-Seyler, 2001). Members of the genus Lactococcus and aerobic bacteria possess alcohol dehydrogenase (Schleifer et al., 1985) are used extensively in the dairy (ADH) activity and are therefore capable of oxidizing and food fermentation industry, a multibillion-dollar ethanol to acetaldehyde. However, the ADH activity of biotech industry. Lactococcus lactis has been the major Lactococcus spp., except Lactococcus lactis ssp. lactis, bacteria used in cheese manufacture for over 8,000 yr, has not been widely determined, though they play an with an excess of 1,000 varieties worldwide (Sandine important role as the starter for most cheesemaking and Elliker, 1970). Currently, the genus comprises 9 technologies. Cheese is a functional food recognized species and 4 subspecies with validly published names as an aid to digestion. In the current study, the ADH T (Parte, 2014). activity of Lactococcus chungangensis CAU 28 and 11 Several metabolic properties of Lactococcus serve reference strains from the genus Lactococcus was de- special functions that directly or indirectly affect termined. Only 5 strains, 3 of dairy origin, L. lactis processes, such as flavor development and ripening of ssp.
    [Show full text]
  • 2021.02.09.430557V1.Full.Pdf
    bioRxiv preprint doi: https://doi.org/10.1101/2021.02.09.430557; this version posted February 10, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Characterization of a Novel Type Homoserine Dehydrogenase Only with High 2 Oxidation Activity from Arthrobacter nicotinovorans 3 Xinxin Lianga, Huaxiang Denga, Yajun Baib, Tai-Ping Fanc, Xiaohui Zhengb*, Yujie 4 Caia* 5 a The Key Laboratory of Industrial Biotechnology, Ministry of Education, School of 6 Biotechnology, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China 7 b College of Life Sciences, Northwest University, Xi’an, Shanxi 710069, China 8 c Department of Pharmacology, University of Cambridge, Cambridge CB2 1T, UK 9 First author: Xinxin Liang 10 a* Corresponding authors: Yujie Cai 11 The Key Laboratory of Industrial Biotechnology, Ministry of Education, School of 12 Biotechnology, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China 13 Tel.: +86-18961727911 14 Fax: +86-0551-85327725 15 E-mail: [email protected] 16 Address: Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China 17 b* Xiaohui Zheng 18 E-mail: [email protected] 19 Address: College of Life Sciences, Northwest University, Xi’an, Shanxi 710069, 20 China bioRxiv preprint doi: https://doi.org/10.1101/2021.02.09.430557; this version posted February 10, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 21 Abstract 22 Homoserine dehydrogenase (HSD) is a key enzyme in the synthesis pathway of 23 the aspartate family of amino acids.
    [Show full text]
  • Characterization and Directed Evolution of an Alcohol Dehydrogenase
    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 1497 Characterization and Directed Evolution of an Alcohol Dehydrogenase A Study Towards Understanding of Three Central Aspects of Substrate Selectivity EMIL HAMNEVIK ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6214 ISBN 978-91-554-9875-7 UPPSALA urn:nbn:se:uu:diva-318984 2017 Dissertation presented at Uppsala University to be publicly examined in BMC A1:111A, Husargatan 3, Uppsala, Friday, 19 May 2017 at 09:15 for the degree of Doctor of Philosophy. The examination will be conducted in English. Faculty examiner: Professor Gerrit Poelarends (University of Groningen). Abstract Hamnevik, E. 2017. Characterization and Directed Evolution of an Alcohol Dehydrogenase. A Study Towards Understanding of Three Central Aspects of Substrate Selectivity. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 1497. 95 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-554-9875-7. Many different chemicals are used in the everyday life, like detergents and pharmaceuticals. However, their production has a big impact on health and environment as much of the raw materials are not renewable and the standard ways of production in many cases includes toxic and environmentally hazardous components. As the population and as the life standard increases all over the planet, the demand for different important chemicals, like pharmaceuticals, will increase. A way to handle this is to apply the concept of Green chemistry, where biocatalysis, in the form of enzymes, is a very good alternative. Enzymes do not normally function in industrial processes and needs modifications through protein engineering to cope in such conditions.
    [Show full text]
  • Alcohol Dehydrogenase from Saccharomyces Cerevisiae
    Alcohol Dehydrogenase from Saccharomyces cerevisiae Catalog Number A7011 Storage Temperature –20 °C CAS RN 9031-72-5 This product is supplied as a lyophilized powder EC 1.1.1.1 containing £2% citrate buffer salts. Synonyms: ADH; Alcohol:NAD+ oxidoreductase; Alcohol Dehydrogenase from baker’s yeast Specific activity: ³300 units/mg protein Product Description Unit definition: One unit will convert 1.0 mmole of Alcohol dehydrogenase can be used for the enzymatic ethanol to acetaldehyde per minute at pH 8.8 at 25 °C. determination of low concentrations of ethanol in 1 aqueous samples. Protein: ³90% (UV absorbance) 2,3 Molecular weight: 141-151 kDa Extinction coefficient:5 E1% = 14.6 (water, 280 nm) The yeast enzyme is a tetramer containing 4 equal Precautions and Disclaimer subunits. The active site of each subunit contains a zinc This product is for R&D use only, not for drug, atom.4 Each active site also contains 2 reactive 5-7 household, or other uses. Please consult the Material sulfhydryl groups and a histidine residue. Safety Data Sheet for information regarding hazards and safe handling practices. Isoelectric point:8 5.4-5.8 4 Preparation Instructions Optimal pH: 8.6-9.0 The lyophilized powder is soluble in water (1 mg/ml), yielding a clear to slightly hazy solution. Cofactors: b-NAD and b-NADH Storage/Stability Substrates: Yeast ADH is most active with ethanol and The product ships on dry ice and storage at –20 °C is its activity decreases as the size of the alcohol 9 8 recommended. When stored at –20 °C, the enzyme increases or decreases.
    [Show full text]
  • Fetal Alcohol Syndrome and Fatty Acid Ethyl Esters
    003 1-3998/92/3 105-0492$03.00/0 PEDIATRIC RESEARCH Vol. 31. No. 5, 1992 Copyright O 1992 International Pediatric Research Foundation, Inc. Prinr1.d in U.S. A. Fetal Alcohol Syndrome and Fatty Acid Ethyl Esters CYNTHIA F. BEARER, SUSAN COULD, RENEE EMERSON, PAULA KINNUNEN, AND CYNTHIA S. COOK Children's Hospital Oakland Research Institute, Oakland, Calfirnia 94609 [C.F.B., S.G., R.E.]; Department of Medicine, Washington University, St. Louis, Missouri 63110 [P.K.];and Departmenf of Growth and Development, University of Calijbrnia. Sun Francisco, Calfirnia 94143 [C.S.C.] ABSTRACT. Fetal alcohol syndrome is the leading known The mechanism of ethanol-induced teratogenesis is unknown, cause of mental retardation. The syndrome, defined as and current hypotheses include altered placental nutrient trans- growth retardation, midface hypoplasia, and neurologic port, fetal hypoxia due to umbilical artery constriction and dysfunction, represents only part of the spectrum of fetal increased oxygen consumption secondary to ethanol, abnormal alcohol effects. The biochemical mechanism of teratoge- muscle organogenesis, prostaglandin and fetal CAMPeffects, and nesis is unknown. In adults, metabolites of ethanol, FAEE, altered hormone metabolism (5). However, currently available are known to accumulate in major organs. The formation data do not identify the primary site of action for alcohol or any of FAEE is catalyzed by a family of enzymes, FAEE biochemical mechanism of fetal alcohol toxicity. synthases. Our hypothesis is that accumulation of FAEE Ethanol metabolism in mammals occurs primarily in the liver in the embryo results in fetal alcohol syndrome. We have via two different pathways, oxidation of ethanol to acetaldehyde developed assays for FAEE and FAEE synthase activity by either ADH or the microsomal ethanol-oxidizing system (6).
    [Show full text]
  • Ab272530 Isocitrate Dehydrogenase Assay Kit
    Version 1 Last updated 12 May 2020 ab272530 Isocitrate Dehydrogenase Assay Kit View ab272530 Isocitrate Dehydrogenase Assay Kit datasheet: www.abcam.com/ab272530 (use www.abcam.cn/ab272530 for China, or www.abcam.co.jp/ab272530 for Japan) For quantitative determination of Isocitrate Dehydrogenase activity and evaluation of drug effects on its metabolism. This product is for research use only and is not intended for diagnostic use. Copyright © 2020 Abcam. All rights reserved Table of Contents 1. Overview 1 2. Protocol Summary 2 3. Precautions 3 4. Storage and Stability 3 5. Limitations 4 6. Materials Supplied 4 7. Materials Required, Not Supplied 5 8. Technical Hints 6 9. Reagent Preparation 7 10. Sample Preparation 8 11. Assay Procedure 9 12. Calculations 11 13. Typical Data 12 14. Notes 13 Copyright © 2020 Abcam. All rights reserved 1. Overview This kit (ab272530) measures the activity of the NADP+ isoforms. Mutations in IDH1 and IDH2 have been linked with various brain tumors and acute myeloid leukemia. Our non-radioactive, colorimetric IDH assay is based on the reduction of the tetrazolium salt MTT in a NADPH- coupled enzymatic reaction to a reduced form of MTT which exhibits an absorption maximum at 565 nm. The increase in absorbance at 565 nm is directly proportional to the enzyme activity. Fast and sensitive. Linear detection range (20 µL sample): 0.1 to 100 U/L for 30 min reaction. Convenient and high-throughput. Homogeneous "mix-incubate- measure" type assay. Can be readily automated on HTS liquid handling systems for processing thousands of samples per day. ab272530 Alcohol Dehydrogenase Assay Kit 1 2.
    [Show full text]
  • The Role of AKR1B10 in Physiology and Pathophysiology
    H OH metabolites OH Review The Role of AKR1B10 in Physiology and Pathophysiology Satoshi Endo 1,* , Toshiyuki Matsunaga 2 and Toru Nishinaka 3 1 Laboratory of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan 2 Education Center of Green Pharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 502-8585, Japan; [email protected] 3 Laboratory of Biochemistry, Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi 584-8540, Osaka, Japan; [email protected] * Correspondence: [email protected] Abstract: AKR1B10 is a human nicotinamide adenine dinucleotide phosphate (NADPH)-dependent reductase belonging to the aldo-keto reductase (AKR) 1B subfamily. It catalyzes the reduction of aldehydes, some ketones and quinones, and interacts with acetyl-CoA carboxylase and heat shock protein 90α. The enzyme is highly expressed in epithelial cells of the stomach and intestine, but down-regulated in gastrointestinal cancers and inflammatory bowel diseases. In contrast, AKR1B10 expression is low in other tissues, where the enzyme is upregulated in cancers, as well as in non- alcoholic fatty liver disease and several skin diseases. In addition, the enzyme’s expression is elevated in cancer cells resistant to clinical anti-cancer drugs. Thus, growing evidence supports AKR1B10 as a potential target for diagnosing and treating these diseases. Herein, we reviewed the literature on the roles of AKR1B10 in a healthy gastrointestinal tract, the development and progression of cancers and acquired chemoresistance, in addition to its gene regulation, functions, and inhibitors. Keywords: aldo-keto reductases; AKR1B10; biomarkers Citation: Endo, S.; Matsunaga, T.; Nishinaka, T. The Role of AKR1B10 in 1. Introduction Physiology and Pathophysiology.
    [Show full text]